• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail
-

GRN No. 568

Apoaequorin

Intended Use: For use as an ingredient in dairy products (shakes and smoothies) at a level intended to provide 6 milligrams of apoaequorin per serving.
Basis: Scientific procedures
Notifier: Quincy Bioscience Manufacturing, Inc.
Notifier Address: 301 S Westfield Road, Suite 200, Madison, WI 53717
Date of filing: Mar 17, 2015
GRAS Notice (releasable information): GRN 568 (in PDF) (2.5 MB)
Date of closure: Oct 21, 2015
FDA's Letter: At the notifier's request, FDA ceased to evaluate this notice

2362  

-
-